In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...

Drug developers will be able to use alternatives to animal testing and possibly get new products to market faster under draft guidance issued Wednesday by the FDA. In a press release, officials said ...

Add Yahoo as a preferred source to see more of our stories on Google. A vast number of chemicals are registered for production and use around the world. But only a portion have been thoroughly ...

New plan backs researchers to seize on new and developing opportunities to phase out animal tests with specific commitments for the coming years. Animal testing in science is set to be phased out ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.

Other countries, like the U.K, the United States and the European Union have all dedicated funding and detailed roadmaps to ...

Initiative focuses on innovation, partnerships, and advocacy as part of $500 million investment in driving change Understanding that stakeholders across drug development must collaborate to pursue ...

As the fervor around ending animal testing in drug development has grown since President Donald Trump started his second term, a group of nonprofits, corporations and regulators has been meeting to ...

Animal testing has been widely debated for many years. Following a large public petition, the European Commission is developing a roadmap to outline how all animal testing for chemical safety ...

Katie has a PhD in maths, specializing in the intersection of dynamical systems and number theory. She reports on topics from maths and history to society and animals. Katie has a PhD in maths, ...